https://www.selleckchem.com/pr....oducts/brensocatib.h
This study aimed to examine the association of less-certain indication of chronic total occlusion percutaneous coronary intervention (CTO-PCI) with subsequent clinical outcomes. The impact of patient symptoms, myocardial viability, and clinical and anatomic risk on long-term outcomes is underdetermined. Consecutive patients undergoing CTO-PCI at a large-volume single center between 2010 and 2013 were included. Central adjudication was used to assess the appropriateness of three prespecified indications. The primary outcome was the 5